Type XVI collagen is expressed in factor XIIIa+ monocyte-derived dermal dendrocytes and constitutes a potential substrate for factor XIIIa

Atsushi Akagi, Shingo Tajima, Akira Ishibashi, Yuko Matsubara, Makoto Takehana, Shizuko Kobayashi, Noriko Yamaguchi

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

We have previously reported that connective tissue cells in the superficial dermis preferentially express α1(XVI) collagen rather than those in the lower dermis. Double immunofluorescence labeling using the antibodies for α1(XVI) collagen and factor XIIIa (plasma transglutaminase), which is a marker of dermal dendrocytes, demonstrated that both antibodies reacted with the same cells in the superficial dermis of normal skin as well as the lesional skins of dermal dendrocyte-related disorders, dermatofibroma, and psoriasis. Dermal dendrocytes are considered to be established by a culture of peripheral blood monocytes in the presence of granulocyte macrophage-colony stimulating factor and interleukin-4. Reverse transcription-polymerase chain reaction, metabolic labeling, and immunofluorescence studies demonstrated that treatment of CD14+ peripheral blood monocytes with granulocyte macrophage-colony stimulating factor/interleukin-4 over a period of 8 d resulted in the induction of α1(XVI) collagen as well as factor XIIIa. The physiologic significance of colocalization of α1(XVI) collagen and factor XIIIa in the tissue and their coordinate induction in CD14+ monocyte-derived dendritic cells in vitro was studied. Considerable incorporation of [3H]putrescine by factor XIIIa into recombinant noncollagenous domain (NC) 11 but not into collagenous domain (COL) 1·NC1 domain of the α1(XVI) polypeptide was found. Incubation of recombinant NC11 of α1(XVI) polypeptide with factor XIIIa in vitro produced a covalent cross-linking complex on sodium dodecylsulfate-polyacrylamide gel electrophoresis. The results indicate that α1(XVI) collagen is constitutively expressed by most dermal dendrocytes in the skin and dendritic cells differentiated from peripheral blood monocytes in vitro. Type XVI collagen is expressed in factor XIIIa+ dermal dendrocytes and may form an intermolecular cross-linking through NC11 domain by the reaction catalyzed by factor XIIIa contributing to the structural integrity of factor XIIIa+ dendritic cell-rich tissues.

Original languageEnglish
Pages (from-to)267-274
Number of pages8
JournalJournal of Investigative Dermatology
Volume118
Issue number2
DOIs
Publication statusPublished - 2002

Fingerprint

Factor XIIIa
Monocytes
Collagen
Skin
Substrates
Dermis
Blood
Tissue
Granulocyte-Macrophage Colony-Stimulating Factor
Interleukin-4
Dendritic Cells
Labeling
Fluorescent Antibody Technique
Benign Fibrous Histiocytoma
Connective Tissue Cells
Peptides
Putrescine
Langerhans Cells
Antibodies
Polymerase chain reaction

Keywords

  • Collagen XVI
  • Cross-linking
  • Dendrocyte
  • Factor XIIIa
  • Monocyte

ASJC Scopus subject areas

  • Dermatology

Cite this

Type XVI collagen is expressed in factor XIIIa+ monocyte-derived dermal dendrocytes and constitutes a potential substrate for factor XIIIa. / Akagi, Atsushi; Tajima, Shingo; Ishibashi, Akira; Matsubara, Yuko; Takehana, Makoto; Kobayashi, Shizuko; Yamaguchi, Noriko.

In: Journal of Investigative Dermatology, Vol. 118, No. 2, 2002, p. 267-274.

Research output: Contribution to journalArticle

Akagi, Atsushi ; Tajima, Shingo ; Ishibashi, Akira ; Matsubara, Yuko ; Takehana, Makoto ; Kobayashi, Shizuko ; Yamaguchi, Noriko. / Type XVI collagen is expressed in factor XIIIa+ monocyte-derived dermal dendrocytes and constitutes a potential substrate for factor XIIIa. In: Journal of Investigative Dermatology. 2002 ; Vol. 118, No. 2. pp. 267-274.
@article{9db78cf918a44f4faf6358a2153aa2f1,
title = "Type XVI collagen is expressed in factor XIIIa+ monocyte-derived dermal dendrocytes and constitutes a potential substrate for factor XIIIa",
abstract = "We have previously reported that connective tissue cells in the superficial dermis preferentially express α1(XVI) collagen rather than those in the lower dermis. Double immunofluorescence labeling using the antibodies for α1(XVI) collagen and factor XIIIa (plasma transglutaminase), which is a marker of dermal dendrocytes, demonstrated that both antibodies reacted with the same cells in the superficial dermis of normal skin as well as the lesional skins of dermal dendrocyte-related disorders, dermatofibroma, and psoriasis. Dermal dendrocytes are considered to be established by a culture of peripheral blood monocytes in the presence of granulocyte macrophage-colony stimulating factor and interleukin-4. Reverse transcription-polymerase chain reaction, metabolic labeling, and immunofluorescence studies demonstrated that treatment of CD14+ peripheral blood monocytes with granulocyte macrophage-colony stimulating factor/interleukin-4 over a period of 8 d resulted in the induction of α1(XVI) collagen as well as factor XIIIa. The physiologic significance of colocalization of α1(XVI) collagen and factor XIIIa in the tissue and their coordinate induction in CD14+ monocyte-derived dendritic cells in vitro was studied. Considerable incorporation of [3H]putrescine by factor XIIIa into recombinant noncollagenous domain (NC) 11 but not into collagenous domain (COL) 1·NC1 domain of the α1(XVI) polypeptide was found. Incubation of recombinant NC11 of α1(XVI) polypeptide with factor XIIIa in vitro produced a covalent cross-linking complex on sodium dodecylsulfate-polyacrylamide gel electrophoresis. The results indicate that α1(XVI) collagen is constitutively expressed by most dermal dendrocytes in the skin and dendritic cells differentiated from peripheral blood monocytes in vitro. Type XVI collagen is expressed in factor XIIIa+ dermal dendrocytes and may form an intermolecular cross-linking through NC11 domain by the reaction catalyzed by factor XIIIa contributing to the structural integrity of factor XIIIa+ dendritic cell-rich tissues.",
keywords = "Collagen XVI, Cross-linking, Dendrocyte, Factor XIIIa, Monocyte",
author = "Atsushi Akagi and Shingo Tajima and Akira Ishibashi and Yuko Matsubara and Makoto Takehana and Shizuko Kobayashi and Noriko Yamaguchi",
year = "2002",
doi = "10.1046/j.0022-202x.2001.01666.x",
language = "English",
volume = "118",
pages = "267--274",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Type XVI collagen is expressed in factor XIIIa+ monocyte-derived dermal dendrocytes and constitutes a potential substrate for factor XIIIa

AU - Akagi, Atsushi

AU - Tajima, Shingo

AU - Ishibashi, Akira

AU - Matsubara, Yuko

AU - Takehana, Makoto

AU - Kobayashi, Shizuko

AU - Yamaguchi, Noriko

PY - 2002

Y1 - 2002

N2 - We have previously reported that connective tissue cells in the superficial dermis preferentially express α1(XVI) collagen rather than those in the lower dermis. Double immunofluorescence labeling using the antibodies for α1(XVI) collagen and factor XIIIa (plasma transglutaminase), which is a marker of dermal dendrocytes, demonstrated that both antibodies reacted with the same cells in the superficial dermis of normal skin as well as the lesional skins of dermal dendrocyte-related disorders, dermatofibroma, and psoriasis. Dermal dendrocytes are considered to be established by a culture of peripheral blood monocytes in the presence of granulocyte macrophage-colony stimulating factor and interleukin-4. Reverse transcription-polymerase chain reaction, metabolic labeling, and immunofluorescence studies demonstrated that treatment of CD14+ peripheral blood monocytes with granulocyte macrophage-colony stimulating factor/interleukin-4 over a period of 8 d resulted in the induction of α1(XVI) collagen as well as factor XIIIa. The physiologic significance of colocalization of α1(XVI) collagen and factor XIIIa in the tissue and their coordinate induction in CD14+ monocyte-derived dendritic cells in vitro was studied. Considerable incorporation of [3H]putrescine by factor XIIIa into recombinant noncollagenous domain (NC) 11 but not into collagenous domain (COL) 1·NC1 domain of the α1(XVI) polypeptide was found. Incubation of recombinant NC11 of α1(XVI) polypeptide with factor XIIIa in vitro produced a covalent cross-linking complex on sodium dodecylsulfate-polyacrylamide gel electrophoresis. The results indicate that α1(XVI) collagen is constitutively expressed by most dermal dendrocytes in the skin and dendritic cells differentiated from peripheral blood monocytes in vitro. Type XVI collagen is expressed in factor XIIIa+ dermal dendrocytes and may form an intermolecular cross-linking through NC11 domain by the reaction catalyzed by factor XIIIa contributing to the structural integrity of factor XIIIa+ dendritic cell-rich tissues.

AB - We have previously reported that connective tissue cells in the superficial dermis preferentially express α1(XVI) collagen rather than those in the lower dermis. Double immunofluorescence labeling using the antibodies for α1(XVI) collagen and factor XIIIa (plasma transglutaminase), which is a marker of dermal dendrocytes, demonstrated that both antibodies reacted with the same cells in the superficial dermis of normal skin as well as the lesional skins of dermal dendrocyte-related disorders, dermatofibroma, and psoriasis. Dermal dendrocytes are considered to be established by a culture of peripheral blood monocytes in the presence of granulocyte macrophage-colony stimulating factor and interleukin-4. Reverse transcription-polymerase chain reaction, metabolic labeling, and immunofluorescence studies demonstrated that treatment of CD14+ peripheral blood monocytes with granulocyte macrophage-colony stimulating factor/interleukin-4 over a period of 8 d resulted in the induction of α1(XVI) collagen as well as factor XIIIa. The physiologic significance of colocalization of α1(XVI) collagen and factor XIIIa in the tissue and their coordinate induction in CD14+ monocyte-derived dendritic cells in vitro was studied. Considerable incorporation of [3H]putrescine by factor XIIIa into recombinant noncollagenous domain (NC) 11 but not into collagenous domain (COL) 1·NC1 domain of the α1(XVI) polypeptide was found. Incubation of recombinant NC11 of α1(XVI) polypeptide with factor XIIIa in vitro produced a covalent cross-linking complex on sodium dodecylsulfate-polyacrylamide gel electrophoresis. The results indicate that α1(XVI) collagen is constitutively expressed by most dermal dendrocytes in the skin and dendritic cells differentiated from peripheral blood monocytes in vitro. Type XVI collagen is expressed in factor XIIIa+ dermal dendrocytes and may form an intermolecular cross-linking through NC11 domain by the reaction catalyzed by factor XIIIa contributing to the structural integrity of factor XIIIa+ dendritic cell-rich tissues.

KW - Collagen XVI

KW - Cross-linking

KW - Dendrocyte

KW - Factor XIIIa

KW - Monocyte

UR - http://www.scopus.com/inward/record.url?scp=0036178616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036178616&partnerID=8YFLogxK

U2 - 10.1046/j.0022-202x.2001.01666.x

DO - 10.1046/j.0022-202x.2001.01666.x

M3 - Article

C2 - 11841543

AN - SCOPUS:0036178616

VL - 118

SP - 267

EP - 274

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 2

ER -